about
Microbubble contrast agents: a new era in ultrasoundUltrasound contrast materials in cardiovascular medicine: from perfusion assessment to molecular imagingTheragnostic ultrasound using microbubbles in the treatment of prostate cancerIntravascular ultrasound catheter to enhance microbubble-based drug delivery via acoustic radiation force.Influences of microbubble diameter and ultrasonic parameters on in vitro sonothrombolysis efficacy.Evaluation of ultrasound-assisted thrombolysis using custom liposomes in a model of retinal vein occlusion.Potentiating intra-arterial sonothrombolysis for acute ischemic stroke by the addition of the ultrasound contrast agents (Optison™ & SonoVue(®))Ultrasonic drug delivery--a general review.Targeted imaging using ultrasound.Design of Albumin-Coated Microbubbles Loaded With Polylactide Nanoparticles.The role of ultrasound in molecular imaging.Ultrasound-induced cavitation: applications in drug and gene delivery.The application of microbubbles for targeted drug delivery.Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.Sonothrombolysis for the treatment of acute stroke: current concepts and future directions.Magnetic targeting and ultrasound mediated drug delivery: benefits, limitations and combination.Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.Properties, characteristics and applications of microbubbles for sonothrombolysis.In vitro evaluation of ultrasound-assisted thrombolysis using a targeted ultrasound contrast agent.Thrombus-targeted perfluorocarbon-containing liposomal bubbles for enhancement of ultrasonic thrombolysis: in vitro and in vivo study.Sonoporation, drug delivery, and gene therapy.Safety and dose-escalation study design of Transcranial Ultrasound in Clinical SONolysis for acute ischemic stroke: the TUCSON Trial.A versatile method for the preparation of particle-loaded microbubbles for multimodality imaging and targeted drug delivery.Bulk manufacture of concentrated oxygen gas-filled microparticles for intravenous oxygen delivery.
P2860
Q24525212-20A4B8E9-795B-4D51-935C-F31FE151A174Q26853667-F8DB0BB2-68F1-4EB3-815C-AF51445878A8Q28067216-86F0C3E5-3F2D-4803-A237-A1FAED3986D0Q30362133-9B2F82CE-E54F-416C-A4D9-C7D0F38FB56EQ30446642-BFE3073E-C16B-46C1-B4EC-E5E2FE825CD3Q30455839-3FEBC9C6-784E-43EE-8416-CCF82B70F611Q30471810-24DD9F1D-66A4-49A0-9A0C-3577F119260FQ30502960-5EF3B611-213F-4ED2-885B-07E9827A9ABDQ30734358-BB3DF2C4-60F0-4851-927F-55248D17862DQ35954495-BC78D076-F487-438E-9A9F-FAACDE6E191BQ35968117-FCF2C2F3-9090-42E0-892A-20008A63FC9AQ36640312-461E9880-564A-4694-9027-8025FB9EE36DQ36945842-29894DF9-A774-4659-9D19-1AE3ACC884B4Q37073531-11B8FC94-57BC-472E-85B9-95BE77DFB2E7Q37838429-FA3B8D8C-EABC-4914-87C8-4068419CFC0DQ38012538-8D173C45-9D66-47E6-B4F0-3035F0729680Q38170031-DC84DD57-14F0-4C23-999A-7805414A87DFQ38176653-FA170D4C-53D7-449E-AAC0-C5141673A3F0Q43066831-66CAF229-411F-448C-A125-4E4B356C96EBQ44077486-2D9D53D3-80C4-4912-9C9A-BDF51F6E88FDQ45858068-8E0A4C3E-D75B-4D65-BDD2-89F977B98393Q46112620-8BA0FD79-D1B1-4639-8288-856D12E713B0Q48118371-BFC6EE24-6C6F-40FE-AB02-D32A291E6C68Q48502285-15E8E691-0F4D-4469-B1CE-218D2D7FDF31
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Binding and lysing of blood clots using MRX-408.
@ast
Binding and lysing of blood clots using MRX-408.
@en
type
label
Binding and lysing of blood clots using MRX-408.
@ast
Binding and lysing of blood clots using MRX-408.
@en
prefLabel
Binding and lysing of blood clots using MRX-408.
@ast
Binding and lysing of blood clots using MRX-408.
@en
P2093
P1476
Binding and lysing of blood clots using MRX-408.
@en
P2093
McCreery TP
Sweitzer RH
Vielhauer MD
P304
P356
10.1097/00004424-199812000-00006
P577
1998-12-01T00:00:00Z